SEMPRA (SRE) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:SRE - US8168511090 - Common Stock
88.03 USD
+1.67 (+1.93%)
88.03 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 78% to SRE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 102.01. This target is 15.88% above the current price.
SRE was analyzed by 22 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about SRE.
In the previous month the buy percentage consensus was at a similar level.
SRE was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-24 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-14 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-06 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-28 | Wells Fargo | Initiate | Overweight |
| 2025-10-22 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-10-22 | Jefferies | Maintains | Hold -> Hold |
| 2025-10-20 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2025-10-07 | Evercore ISI Group | Initiate | Outperform |
| 2025-09-25 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-09-24 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-09-24 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-26 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-04 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-10 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-06-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-12 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-04-15 | Jefferies | Maintains | Hold -> Hold |
| 2025-04-09 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-03-26 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-03-20 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-03-04 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-03-03 | Jefferies | Downgrade | Buy -> Hold |
| 2025-02-27 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2025-02-26 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-02-26 | Guggenheim | Maintains | Buy -> Buy |
| 2025-02-26 | UBS | Downgrade | Buy -> Neutral |
| 2025-02-26 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-26 | Goldman Sachs | Downgrade | Buy -> Neutral |
SEMPRA / SRE FAQ
Can you provide the average price target for SEMPRA stock?
22 analysts have analysed SRE and the average price target is 102.01 USD. This implies a price increase of 15.88% is expected in the next year compared to the current price of 88.03.
How do analysts rate SEMPRA (SRE)?
The consensus rating for SEMPRA (SRE) is 78.1818 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed SEMPRA (SRE)?
The number of analysts covering SEMPRA (SRE) is 22.